van der Kleijn E, Vree T B, Baars A M, Wijsman R, Edmunds L C, Knop H J
Br J Clin Pharmacol. 1981;11 Suppl 1(Suppl 1):85S-98S. doi: 10.1111/j.1365-2125.1981.tb01843.x.
1 The clinical pharmacokinetics of the many benzodiazepines used to treat numerous and varied clinical conditions can be influenced by many factors. 2 Combinations of drugs efficacious in the central nervous system can change the onset, intensity and duration of effect as a result of pharmacological, physiological and pharmacokinetic actions. 3 Pharmacokinetic considerations indicate that short to medium long-acting benzodiazepines that depend on only glucuronidation for their major metabolic pathway are the drugs of choice in this category.